Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Annals of the New York Academy of Sciences
|
May 17, 2022
The dual GLP-1 and GLP-2 receptor agonist dapiglutide promotes barrier function in murine short bowel
Johannes Reiner, Johanna Thiery, Jascha Held, et al.
Visceral Medicine
|
August 9, 2023
<i>C. perfringens</i> Blood Stream Infection due to Nontransmural Ischemia of the Esophagus, Stomach, and Left Colon: Case Report
Johannes Reiner, Katharina Reichenbach, Imad Kamaleddine, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 12, 2019
<i>Nod2</i> deficiency functionally impairs adaptation to short bowel syndrome via alterations of the epithelial barrier function
Peggy Berlin, Johannes Reiner, Maria Witte, et al.
Journal of Cell Science
|
April 29, 2011
Phagocytosis of dying tumor cells by human peritoneal mesothelial cells
Britta Janina Wagner, Dennis Lindau, Dagmar Ripper, et al.
Digestive Diseases and Sciences
|
December 21, 2018
Villus Growth, Increased Intestinal Epithelial Sodium Selectivity, and Hyperaldosteronism Are Mechanisms of Adaptation in a Murine Model of Short Bowel Syndrome
Peggy Berlin, Johannes Reiner, Jakob Wobar, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
October 27, 2021
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel
Johannes Reiner, Peggy Berlin, Jascha Held, et al.
Molecular Metabolism
|
March 17, 2025
Glucagon-like peptide-2 pharmacotherapy activates hepatic Farnesoid X receptor-signaling to attenuate resection-associated bile acid loss in mice
Johannes Reiner, Nooshin Mohebali, Jens Kurth, et al.
Cancer Medicine
|
October 18, 2013
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
Heike Niessner, Andrea Forschner, Bernhard Klumpp, et al.
Immunity
|
July 14, 2026
Antigen-restricted Candida albicans Th17 cells link oral-gut immunity and adopt pathogenic features during intestinal inflammation
Gabriela Rios Martini, Philipp Hofmann, Ann-Kristin Kamps, et al.
Gut
|
March 10, 2022
A novel unconventional T cell population enriched in Crohn's disease
Elisa Rosati, Gabriela Rios Martini, Mikhail V Pogorelyy, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Annals of the New York Academy of Sciences
|
May 17, 2022
The dual GLP-1 and GLP-2 receptor agonist dapiglutide promotes barrier function in murine short bowel
Johannes Reiner, Johanna Thiery, Jascha Held, et al.
Visceral Medicine
|
August 9, 2023
<i>C. perfringens</i> Blood Stream Infection due to Nontransmural Ischemia of the Esophagus, Stomach, and Left Colon: Case Report
Johannes Reiner, Katharina Reichenbach, Imad Kamaleddine, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 12, 2019
<i>Nod2</i> deficiency functionally impairs adaptation to short bowel syndrome via alterations of the epithelial barrier function
Peggy Berlin, Johannes Reiner, Maria Witte, et al.
Journal of Cell Science
|
April 29, 2011
Phagocytosis of dying tumor cells by human peritoneal mesothelial cells
Britta Janina Wagner, Dennis Lindau, Dagmar Ripper, et al.
Digestive Diseases and Sciences
|
December 21, 2018
Villus Growth, Increased Intestinal Epithelial Sodium Selectivity, and Hyperaldosteronism Are Mechanisms of Adaptation in a Murine Model of Short Bowel Syndrome
Peggy Berlin, Johannes Reiner, Jakob Wobar, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
October 27, 2021
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel
Johannes Reiner, Peggy Berlin, Jascha Held, et al.
Molecular Metabolism
|
March 17, 2025
Glucagon-like peptide-2 pharmacotherapy activates hepatic Farnesoid X receptor-signaling to attenuate resection-associated bile acid loss in mice
Johannes Reiner, Nooshin Mohebali, Jens Kurth, et al.
Cancer Medicine
|
October 18, 2013
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
Heike Niessner, Andrea Forschner, Bernhard Klumpp, et al.
Immunity
|
July 14, 2026
Antigen-restricted Candida albicans Th17 cells link oral-gut immunity and adopt pathogenic features during intestinal inflammation
Gabriela Rios Martini, Philipp Hofmann, Ann-Kristin Kamps, et al.
Gut
|
March 10, 2022
A novel unconventional T cell population enriched in Crohn's disease
Elisa Rosati, Gabriela Rios Martini, Mikhail V Pogorelyy, et al.
Page
of 3